To demonstrate that exon skipping cross-correction via snRNA is effective also with other types of myogenic cells, we co-cultured DMD-U7 TIM and WT TIM cells with two different DMD myogenic cell types, either mesoangioblasts (DMDhMABs) or MyoD-converted Fibroblasts (DMDMyoDERTFbs) derived from DMD patients with the same mutation. Here, DMD is linked to Duchenne muscular dystrophy.